
TWENTY-FOUR GENES ARE UPREGULATED
IN PATIENTS WITH HYPOSPADIAS Karabulut R1, Turkyilmaz Z1, Sonmez K1, Kumas G2, Ergun SG2, Ergun MA2,*, Basaklar AC1 *Corresponding Author: Mehmet A. Ergun, M.D., Ph.D., Department of Medical Genetics, Gazi University
Faculty of Medicine, Besevler, Ankara, Turkey; Tel.: +90 312 2024637; Fax. +90 312 2024635; E-mail:
aliergun@gazi.edu.tr page: 39
|
MATERIALS AND METHODS
Patients. A total of eight patients with isolated
distal (subcoronal) hypospadias (mean age 6.8;
range 2-10 years) and five healthy circumcised controls
(mean age 6.5; range 2-10 years) were enrolled
in this study. The penile skin tissue specimens obtained
at surgery during hypospadias repair or elective
circumcision were divided into two groups:
children with hypospadias (n = 8), and normal controls
(n = 5). Informed consent was obtained from
the parents/guardians of all the children.
Samples were flash frozen with liquid nitrogen
and stored at –80 °C until further processing.
The gene expression studies were assessed using
Genechip® Primeview™ Human Gene Expression
Array (Affymetrix, Santa Clara, CA, USA) which
contain more than 53,000 probes including over
36,000 transcripts and variants.
RNA Isolation. Samples were distrupted and
powdered under liquid nitrogen with pestle and
mortar. Tissues were transferred into microcentrifuge
tubes and lysated with 1 mL of TRIzol Reagent
(Invitrogen, Carlsbad, CA, USA). All samples were
homogenized using Qiashredder (Qiagen, Valencia,
CA, USA); 0.2 mL chloroform was added to homogenized
samples and centrifuged at 12,000g for
15 min. Upper aqueous phase was transferred into a
new microcentrifuge tube and isolation of the highpurity
total RNA was perfomed using the RNeasy®
Mini Kit (Qiagen) following the manufacturer’s
specifications. The quantity and purity of RNA was
determined using the NanoDrop 1000 spectrophotometer
(Thermo Scientific, Wilmington, DE, USA)
at 260 nm.
Gene Expression Studies. Genechip® Primeview
™ Human Gene Expression Array (Affymetrix)
was used for gene expression studies. Five hundred
ng of total RNA was reverse transcribed, amplified
and biotin-labelled with Genechip 3’IVT (in vitro
transcription) Express Kit (Affy-metrix) according
to manufacturer’s instructions. aRNAs were then
purified with magnetic beads and after fragmentation of purified biotinylated aRNAs, samples were
loaded to Genechips for subsequent hybridization.
Afterwards, Genechips were washed and stained on
the Fluidics station with specified protocol.
Statistical Analysis. Signal intensities were
acquired by Genechip Scanner 3000 7G (Affymetrix)
to generate cell intensity files (CEL). Statistical
analysis was performed using Partek Genomics
Suite software (Partek Inc., St. Louis, MO, USA).
Robust multi-array average (RMA) algorithm was
used for data normalization. One-way analysis of
variance (ANOVA) was used when >2 groups were
compared, followed the by t-test. The statistical
significance level was set at false discovery rate
((FDR) p <0.05 to minimize false identificaion of
genes. Greater than 2-fold changes were analyzed
for up or down regulated genes. Hierarchical clustering
based on genes and samples was performed
with Partek Genomics Suite Software (Partek Inc.).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|